A corporate R&D metric Online publication date: Tue, 26-May-2009
by Kevin J. Kennedy, John D. Holmfeld
International Journal of Technology Management (IJTM), Vol. 4, No. 6, 1989
Abstract: An examination of corporate R&D expenditure and science publication patterns is presented. In general, large corporations with traditionally excellent research centres maintain a strong science publication performance. However, large companies with correspondingly significant R&D expenditures, such as the top two automobile manufacturers, can exhibit relatively poor scientific publication performance per R&D dollar spent, depending upon the industrial sector. Pharmaceutical companies, typically with 20,000 to 40,000 employees, exhibit R&D expenditures of the order of 6.5 to 12% of sales. These companies achieve the highest individual and aggregate publication performance, per R&D dollar invested. Smaller, high-technology firms, often with fewer than 5000 employees, evidence little or no science publication contributions. In these firms, either product development assumes R&D expenditures or technology transfer via scientific publication is not taking place. Hence, corporate restructuring and disaggregation may significantly alter the nature of the technological enterprise.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology Management (IJTM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook